Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd.

Share · JP3921300004 (XTKS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Immuno-Biological Laboratories Co., Ltd.
No Price
Closing Price XTKS 28.04.2026: 1.387,00 JPY
28.04.2026 06:30
Current Prices from Immuno-Biological Laboratories Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
4570.T
JPY
28.04.2026 06:30
1.387,00 JPY
-9,00 JPY
-0,64 %
Share Float & Liquidity
Free Float 79,83 %
Shares Float 7,43 M
Shares Outstanding 9,31 M
Company Profile for Immuno-Biological Laboratories Co., Ltd. Share
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer's disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.

Company Data

Name Immuno-Biological Laboratories Co., Ltd.
Company Immuno-Biological Laboratories Co., Ltd.
Website https://www.ibl-japan.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3921300004
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Tsutomu Seito
Market Capitalization 13 Mrd.
Country Japan
Currency JPY
Employees 0,1 T
Address Fujioka Laboratory, 375-0005 Fujioka
IPO Date 2007-08-15
Dividends from 'Immuno-Biological Laboratories Co., Ltd.'
Ex-Date Dividend per Share
30.03.2026 4,78 JPY
27.03.2013 50,00 JPY

Stock Splits

Date Split
26.09.2013 10:1

Ticker Symbols

Name Symbol
Tokyo 4570.T
More Shares
Investors who hold Immuno-Biological Laboratories Co., Ltd. also have the following shares in their portfolio:
G.SACHS FDS-EUR.COR.EUR A
G.SACHS FDS-EUR.COR.EUR A Fund
PG & E CORP
PG & E CORP Share